Prestige Brands Visits Doctors To Cure Slumping Monistat Sales
This article was originally published in The Tan Sheet
Executive Summary
The firm in the second half of 2015 plans six initiatives to influence health care professionals on recommending Monistat for patients, CEO Matthew Mannelly says. Sales of Monistat have slid since a previous owner of the brand stopped marketing to health care professionals.
You may also be interested in...
Dentek Consumption Dip Slows Prestige Sales Despite Digestion, Eye Care Gains
Prestige Consumer Healthcare sales in North America in its latest quarter fell 3.9% as retailers slowed on orders of Dentek oral care products. Compound W and Nix lice treatment brands have ‘runway’ for long-term growth on line extensions and marketing.
Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning
Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.
Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning
Prestige Brands has $69m deal to divest its household cleaning business, its final non-OTC assets.. The firm will keep its “power core” OTC brands including Monistat, Summer’s Eve and Goody’s as its marketing focus.